Literature DB >> 20016025

Arcuate nucleus proopiomelanocortin neurons mediate the acute anorectic actions of leukemia inhibitory factor via gp130.

Aaron J Grossberg1, Jarrad M Scarlett, XinXia Zhu, Darren D Bowe, Ayesha K Batra, Theodore P Braun, Daniel L Marks.   

Abstract

The proinflammatory cytokine leukemia inhibitory factor (LIF) is induced in disease states and is known to inhibit food intake when administered centrally. However, the neural pathways underlying this effect are not well understood. We demonstrate that LIF acutely inhibits food intake by directly activating pro-opiomelanocortin (POMC) neurons in the arcuate nucleus of the hypothalamus. We show that arcuate POMC neurons express the LIF-R, and that LIF stimulates the release of the anorexigenic peptide, alpha-MSH from ex vivo hypothalami. Transgenic mice lacking gp130, the signal transducing subunit of the LIF-R complex, specifically in POMC neurons fail to respond to LIF. Furthermore, LIF does not stimulate the release of alpha-MSH from the transgenic hypothalamic explants. These findings indicate that POMC neurons mediate the acute anorectic actions of central LIF administration and provide a mechanistic link between inflammation and food intake.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20016025      PMCID: PMC2817620          DOI: 10.1210/en.2009-1135

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  71 in total

Review 1.  Leukemia-inhibitory factor-neuroimmune modulator of endocrine function.

Authors:  C J Auernhammer; S Melmed
Journal:  Endocr Rev       Date:  2000-06       Impact factor: 19.871

2.  Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: a novel endotoxin-inducible neuro-endocrine interface.

Authors:  Z Wang; S G Ren; S Melmed
Journal:  Endocrinology       Date:  1996-07       Impact factor: 4.736

3.  Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway.

Authors:  D W Ray; S G Ren; S Melmed
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

4.  Anorexia induced by cytokine interactions at pathophysiological concentrations.

Authors:  G Sonti; S E Ilyin; C R Plata-Salamán
Journal:  Am J Physiol       Date:  1996-06

5.  Endogenous brain IL-1 mediates LPS-induced anorexia and hypothalamic cytokine expression.

Authors:  S Layé; G Gheusi; S Cremona; C Combe; K Kelley; R Dantzer; P Parnet
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-07       Impact factor: 3.619

6.  Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice.

Authors:  S Layé; P Parnet; E Goujon; R Dantzer
Journal:  Brain Res Mol Brain Res       Date:  1994-11

7.  Rat and mouse proopiomelanocortin gene sequences target tissue-specific expression to the pituitary gland but not to the hypothalamus of transgenic mice.

Authors:  M Rubinstein; M Mortrud; B Liu; M J Low
Journal:  Neuroendocrinology       Date:  1993-10       Impact factor: 4.914

8.  Endotoxin-induced appearance of immunoreactive interleukin-1 beta in ramified microglia in rat brain: a light and electron microscopic study.

Authors:  A M Van Dam; J Bauer; F J Tilders; F Berkenbosch
Journal:  Neuroscience       Date:  1995-04       Impact factor: 3.590

9.  Increased plasma levels of human interleukin for DA1.a cells/leukemia inhibitory factor in sepsis correlate with shock and poor prognosis.

Authors:  D Villers; T Dao; J M Nguyen; E Bironneau; A Godard; M Moreau; D De Groote; F Nicolas; J P Soulillou; I Anegon
Journal:  J Infect Dis       Date:  1995-01       Impact factor: 5.226

10.  Anorexia induced by activators of the signal transducer gp 130.

Authors:  C R Plata-Salamán
Journal:  Neuroreport       Date:  1996-02-29       Impact factor: 1.837

View more
  29 in total

Review 1.  Adipose tissue and inflammatory bowel disease pathogenesis.

Authors:  Christopher Fink; Iordanes Karagiannides; Kyriaki Bakirtzi; Charalabos Pothoulakis
Journal:  Inflamm Bowel Dis       Date:  2012-03-08       Impact factor: 5.325

Review 2.  Hypothalamic mechanisms in cachexia.

Authors:  Aaron J Grossberg; Jarrad M Scarlett; Daniel L Marks
Journal:  Physiol Behav       Date:  2010-03-25

3.  Inflammation-induced lethargy is mediated by suppression of orexin neuron activity.

Authors:  Aaron J Grossberg; XinXia Zhu; Gina M Leinninger; Peter R Levasseur; Theodore P Braun; Martin G Myers; Daniel L Marks
Journal:  J Neurosci       Date:  2011-08-03       Impact factor: 6.167

Review 4.  Neuropeptides in the pathophysiology and treatment of cachexia.

Authors:  Stephanie M Krasnow; Daniel L Marks
Journal:  Curr Opin Support Palliat Care       Date:  2010-12       Impact factor: 2.302

Review 5.  Hypothalamic inflammation: a double-edged sword to nutritional diseases.

Authors:  Dongsheng Cai; Tiewen Liu
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

6.  Hypothalamic signaling in anorexia induced by indispensable amino acid deficiency.

Authors:  Xinxia Zhu; Stephanie M Krasnow; Quinn R Roth-Carter; Peter R Levasseur; Theodore P Braun; Aaron J Grossberg; Daniel L Marks
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-10-09       Impact factor: 4.310

7.  Persistent Toll-like receptor 7 stimulation induces behavioral and molecular innate immune tolerance.

Authors:  Katherine A Michaelis; Mason A Norgard; Peter R Levasseur; Brennan Olson; Kevin G Burfeind; Abigail C Buenafe; Xinxia Zhu; Sophia Jeng; Shannon K McWeeney; Daniel L Marks
Journal:  Brain Behav Immun       Date:  2019-09-06       Impact factor: 7.217

8.  Cachexia-associated adipose loss induced by tumor-secreted leukemia inhibitory factor is counterbalanced by decreased leptin.

Authors:  Gurpreet K Arora; Arun Gupta; Sriram Narayanan; Tong Guo; Puneeth Iyengar; Rodney E Infante
Journal:  JCI Insight       Date:  2018-07-26

Review 9.  The central role of hypothalamic inflammation in the acute illness response and cachexia.

Authors:  Kevin G Burfeind; Katherine A Michaelis; Daniel L Marks
Journal:  Semin Cell Dev Biol       Date:  2015-11-03       Impact factor: 7.727

10.  Melanocortin-4 receptor antagonist TCMCB07 ameliorates cancer- and chronic kidney disease-associated cachexia.

Authors:  Xinxia Zhu; Michael F Callahan; Kenneth A Gruber; Marek Szumowski; Daniel L Marks
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.